U.S. Pharmaceuticals & Biotech Stable Growth Stocks

Exelixis

Market Cap: US$11.7b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Medpace Holdings

Market Cap: US$8.5b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Merck

Market Cap: US$192.9b

Operates as a healthcare company worldwide.

Catalyst Pharmaceuticals

Market Cap: US$3.0b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Waters

Market Cap: US$20.8b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Halozyme Therapeutics

Market Cap: US$6.9b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Mettler-Toledo International

Market Cap: US$24.0b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Thermo Fisher Scientific

Market Cap: US$152.1b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Avantor

Market Cap: US$8.8b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Corcept Therapeutics

Market Cap: US$8.2b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Regeneron Pharmaceuticals

Market Cap: US$51.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Jazz Pharmaceuticals

Market Cap: US$6.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Krystal Biotech

Market Cap: US$3.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Eli Lilly

Market Cap: US$662.2b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

ICON

Market Cap: US$10.4b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Gilead Sciences

Market Cap: US$136.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.